pdufa.bio

Tolebrutinib

Updated ยทnext FDA decision on the calendar

Tolebrutinib 1 FDA decision on record below. Every date links its source.

SNY catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Dec 28, 2025 CRLSNY

Questions

When is Tolebrutinib's next FDA decision or readout?

No upcoming catalyst is on our calendar for Tolebrutinib; 1 FDA decision is on record below.

What happened at Tolebrutinib's most recent FDA decision?

On Dec 28, 2025 the FDA issued a Complete Response Letter. The decision page carries the source document and the measured share-price reaction.

Has Tolebrutinib been approved by the FDA?

Not in our records. The FDA issued a Complete Response Letter on Dec 28, 2025.

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.